Larotrectinib

製品コードS5860 バッチS586002

印刷

化学情報

Chemical Structure Synonyms Vitrakvi, LOXO-101, ARRY-470 Storage
(From the date of receipt)		 3 years -20°C powder
化学式
C21H22F2N6O2
分子量 428.44 CAS No. 1223403-58-4
Solubility (25°C)* 体外 DMSO 86 mg/mL (200.72 mM)
Ethanol 86 mg/mL (200.72 mM)
Water Insoluble
体内 （毎回新しく調製した物を用意してください）
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明 Larotrectinib (Vitrakvi, LOXO-101, ARRY-470) is an ATP-competitive, oral administered and highly selective inhibitor of the tropomyosin-related kinase (TRK) family receptors.

プロトコル(参考用のみ)

参考

  • https://pubmed.ncbi.nlm.nih.gov/26216294/

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C [ Cancer Gene Ther, 2025, 10.1038/s41417-025-00874-z] PubMed: 39915607
Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation [ Toxicol Lett, 2025, 406:31-37] PubMed: 39988211
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway [ Cancer Med, 2024, 13(12):e7393] PubMed: 38923428
Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing [ Biomed Pharmacother, 2023, 163:114751] PubMed: 37105073
Establishment and large-scale validation of a three-dimensional tumor model on an array chip for anticancer drug evaluation [ Front Pharmacol, 2022, 13:1032975] PubMed: 36313330
Larotrectinib induces autophagic cell death through AMPK/mTOR signalling in colon cancer [ J Cell Mol Med, 2022, 26(21):5539-5550] PubMed: 36251949
Influence of Tyrosine Kinase Inhibition on OATP1B3-mediated Uptake [ Mol Pharmacol, 2022, MOLPHARM-AR-2021-000287] PubMed: 35383108
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report [ Commun Med (Lond), 2022, 2:80] PubMed: 35789568
Entrectinib Induces Apoptosis and Inhibits the Epithelial-Mesenchymal Transition in Gastric Cancer with NTRK Overexpression [ Int J Mol Sci, 2021, 23(1)395] PubMed: 35008821
TRK inhibitors block NFKB and induce NRF2 in TRK fusion-positive colon cancer [ J Cancer, 2021, 12(21):6356-6362] PubMed: 34659525

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。